Molecular diversity through sugar scaffolds

Drug Discovery Today

Volumn 8, Issue 15, 2003, Pages 701-709

  Le, Giang Thanh ^a   Abbenante, Giovanni ^a   Becker, Bernd ^a   Grathwohl, Matthias ^a   Halliday, Judy ^a   Tometzki, Gerry ^a   Zuegg, Johannes ^a   Meutermans, Wim ^a  

^a Alchemia Pty Ltd   (Australia)

Author keywords

Carbohydrate; Drug discovery; Libraries; Scaffold; Structural diversity

Indexed keywords

CARBOHYDRATE DERIVATIVE; MELANOCORTIN RECEPTOR; N,N DIMETHYLFORMAMIDE; SOMATOSTATIN RECEPTOR; TETRABUTYLAMMONIUM;

CARBOHYDRATE ANALYSIS; COMBINATORIAL CHEMISTRY; DRUG SYNTHESIS; MOLECULAR MIMICRY; PROTEIN FUNCTION; REVIEW;

ANIMALS; CARBOHYDRATES; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 0043123209     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02751-X     Document Type: Review

References (65)

1. Martin E.J., et al. Measuring diversity: experimental design of combinatorial libraries for drug discovery. J. Med. Chem. 38:1995;1431-1436.
2. Dean P.M. Molecular Similarity in Drug Design. 1995;Chapman & Hall.
3. Johnson M.A., Maggiora G.M. Concepts and Application of Molecular Similarity. 1990;Wiley-Interscience.
4. Makara G.M. Measuring molecular similarity and diversity: total pharmacophore diversity. J. Med. Chem. 44:2001;3563-3571.
5. Beno B.R., Mason J.S. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. Drug Discov. Today. 6:2001;251-258.
6. McGregor M.J., Muskal S.M. Pharmacophore fingerprinting. 2. Application to primary library design. J. Chem. Inf. Comput. Sci. 40:2000;117-125.
7. Mason J.S., et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J. Med. Chem. 42:1999;3251-3264.
8. Pearlman R.S., Smith K.M. Metric validation and the receptor-relevant subspace concept. J. Chem. Inf. Comput. Sci. 39:1999;28-35.
9. Brown R.D., Martin Y.C. The information content of 2d and 3d structural descriptors relevant to ligand-receptor binding. J. Chem. Inf. Comput. Sci. 37:1997;1-9.
10. Gorse D., Lahana R. Functional diversity of compound libraries. Curr. Opin. Chem. Biol. 4:2000;287-294.
11. Bourne G.T., et al. b-turn nomenclature: a topographical classification system. Kaumaya P.T.P., Hodges R.S. Peptides: Chemistry, Structure and Biology. 1996;354-355 Mayflower Scientific.
12. Tran T.T., et al. The side-chain classification of loops from high-resolution protein crystal structures. Fields G.B., et al. Peptides for the New Millenium. 2000;320-321 Kluwer Academic Publishers.
13. Farmer P.S. Ariens E.J. Drug Design. 10:1980;119 Academic New York.
14. Zuckermann R.N., et al. Peptoids: a modular approach to drug discovery. Proc. Natl. Acad. Sci. U. S. A. 89:1992;9367-9371.
15. Kahn M., et al. Design, synthesis, and application of peptide secondary structure mimetics. Mini. Rev. Med. Chem. 2:2002;447-462.
16. Janda K.D., et al. Peptidomimetics and peptide backbone modifications. Mini. Rev. Med. Chem. 2:2002;447-462.
17. Rich D.H., et al. Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. J. Med. Chem. 45:2002;541-558.
18. Houghten R.A., et al. New opioid peptides, peptidomimetics, and heterocyclic compounds from combinatorial libraries. Biopolymers. 51:1999;379-390.
19. Bélanger P.C., Dufresne C. Preparation of exo-6-Benzyl- exo-2-(m-hydroxyphenyl)-1-dimethylaminomethylbicyclo[2.2.2]octane. A non-peptide mimetic of enkephalins. Can. J. Chem. 64:1986;1514-1520.
20. Olsen, G.L. et al. (1989) Concepts and progress in the design of peptide mimetics, beta turns and thyrotropin releasing hormone. In Proc. Biotechnol. (U. S. A.), pp. 348-360, Conference Management Association.
21. Kahn M., et al. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics. Bioorg. Med. Chem. Lett. 8:1998;2321-2326.
22. Olsen G., et al. Concepts and progress in the development of peptide mimetics. J. Med. Chem. 36:1993;3039-3049.
23. Gante J. Peptidomimetics - tailored enzyme inhibitors. Angew. Chem. Int. Ed. Engl. 33:1994;1699-1720.
24. Hanessian S., et al. Tetrahydrofuran as a scaffold for peptidomimetics. Application to the design and synthesis of conformationally constrained metalloproteinase inhibitors. Tetrahedron. 56:2000;7643-7660.
25. Ghosh M., et al. Efficient synthesis of a stereochemically defined carbohydrate scaffold: carboxymethyl 2-acetamido-6-azido-4-o-benzyl-2-deoxy-β-D-glucopyranoside. J. Org. Chem. 65:2000;8387-8390.
26. 1 integrin antagonists based on β-D-mannose as a rigid scaffold. Angew. Chem. Int. Ed. Engl. 40:2001;3870-3873.
27. Gruner S., et al. Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds. Chem. Rev. 102:2002;491-514.
28. Schweizer F. Glycosamino acids: building blocks for combinatorial synthesis-implications for drug discovery. Angew. Chem. Int. Ed. Engl. 41:2002;231-253.
29. Peri, F. et al. Carbohydrate-based scaffolds for the generation of sortiments of bioactive compounds, Monatshefte Chem.133, 369-382.
30. Hirschmann R., et al. Nonpeptidal peptidomimetics with a β-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist. J. Am. Chem. Soc. 114:1992;9217-9218.
31. Hirschmann R., et al. De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing β-D-glucose as a novel scaffolding. J. Am. Chem. Soc. 115:1993;12550-12568.
32. Hirschmann R., et al. Synthesis of potent cyclic hexapeptide NK-1 antagonists: use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic. J. Med. Chem. 39:1996;2441-2448.
33. Hirschmann R., et al. Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis. J. Med. Chem. 41:1998;1382-1391.
34. Capozzi G., et al. Design, synthesis and biological activity of carbohydrate containing peptidomimeticis as new ligands for the human Tachykinin NK-2 receptor. Bioorg. Med. Chem. Lett. 12:2002;2263-2266.
35. 3 integrin antagonists. J. Med. Chem. 42:1999;3033-3040.
36. Nicolaou K.C., et al. Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV. Tetrahedron. 53:1997;8751-8778.
37. Moitessier N., et al. Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based. Bioorg. Med. Chem. Lett. 9:2001;511-523.
38. Hanessian S., et al. Design and synthesis of functionalized glycomers as non-peptidic ligands for SH2 binding and as inhibitors of A-431 Human epidermoid and HT-29 colon carcinoma cell lines. Bioorg. Med. Chem. Lett. 10:1999;439-442.
39. Dömling A., Ugi I. Multi-component reactions with isocyanides. Angew. Chem. Int. Ed. Engl. 39:2000;3168-3210.
40. Goebel M., Ugi I. Beyond peptide and nucleic acid combinatorial libraries-applying unions of multicomponent reactions towards the generation of carbohydrate combinatorial libraries. Tetrahedron Lett. 36:1995;6043-6046.
41. Lockhoff O. An access to glycoconjugate lLibraries through multicomponent reactions. Angew. Chem. Int. Ed. Engl. 37:1998;3436-3439.
42. Park W.K.C., et al. Rapid combinatorial synthesis of aminoglycoside aAntibiotic mimetics: use of a polyethylene glycol-linked amine and a neamine-derived aldehyde in multiple component condensation as a strategy for the discovery of new inhibitors of the HIV RNA rev responsive element. J. Am. Chem. Soc. 118:1996;10150-10155.
43. Sutherlin D., et al. Generation of C-glycoside peptide ligands for cell surface carbohydrate receptors using a four-component condensation on solid support. J. Org. Chem. 61:1996;8350-8354.
44. Oertel K., et al. Stereoselective combinatorial Ugi-multicomponent synthesis on solid phase. Angew. Chem. Int. Ed. Engl. 39:2000;1431-1433.
45. Ziegler T., et al. Preparation of bioconjugates through a Ugi reaction. Angew. Chem. Int. Ed. Engl. 39:2000;2109-2112.
46. Balkenhohl F., et al. Combinatorial synthesis of small organic molecules. Angew. Chem. Int. Ed. Engl. 35:1996;2288-2337.
47. Sofia M., et al. Discovery of novel disaccharide antibacterial agents using a combinatorial library approach. J. Med. Chem. 42:1999;3193-3198.
48. Opatz T., et al. D-Glucose as a pentavalent chiral scaffold. Eur. J. Org. Chem. 8:2003;1527-1536.
49. Kallus C., et al. Combinatorial solid-phase synthesis using dGalactose as a chiral five-dimension-diversity scaffold. Tetrahedron Lett. 40:1999;7783-7786.
50. Opatz T., et al. D-Glucose as a multivalent chiral scaffold for combinatorial chemistry. Carbohydr. Res. 337:2002;2089-2110.
51. Hirschmann R., et al. Development of an efficient regio- and stereoselective route to libraries based on the β-D-Glucose scaffold. J. Org. Chem. 65:2000;8307-8316.
52. Sofia M.J., et al. Carbohydrate-based small-molecule scaffolds for the construction of universal pharmacophore mapping libraries. J. Org. Chem. 63:1998;2802-2803.
53. Dekany, G. et al. (2000) Protecting groups for carbohydrate synthesis, PCT WO-00/42057.
54. Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:2001;3-26.
55. Patel Y.C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20:1999;157-198.
56. Csaba Z., Dournaud P. Cellular biology of somatostatin receptors. Neuropeptides. 35:2001;1-23.
57. Reisine T. Somatostatin receptors. Am. J. Physiol. 269:1995;G813-G820.
58. Bauer W., et al. SMS201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1982;1133-1140.
59. Lamberts S.W.J., et al. Drug therapy: Octreotide. N. Engl. J. Med. 334:1996;246-254.
60. Robinson C., Castaner J. Lanreotide acetate. Drugs Future. 19:1994;992-999.
61. Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocr. Rev. 16:1995;427-442.
62. Fisher S.L., et al. Melanocortin-4 receptor: a novel signalling pathway involved in body weight regulation. Int. J. Obes. 23:(Suppl. A):1999;54-58.
63. Campfield L.A., et al. Strategies and potential molecular targets for obesity treatment. Science. 280:1998;1383-1387.
64. Al-Obeidi F., et al. Design of a new class of super potent cyclic α-melanotropins based on quenched dynamics solutions. J. Am. Chem. Soc. 111:1989;3413-3416.
65. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.